The Puerto Rico Pharmaceutical Industry Association raised three specific objections to the recently released study evaluating quality results in drug manufacturing plants outside the U.S. mainland, saying, among other things, the findings were “highly questionable.”
Drugs produced in U.S.-owned and operated pharmaceutical manufacturing plants in Puerto Rico are more likely to have quality problems than those produced by the same firm in a matched plant on the mainland, a study released Tuesday by Ohio State University's Fisher College of Business.
The island’s declining coffee industry got a shot in the arm Wednesday with the opening of Puerto Rico Coffee Roasters’ new $15 million roasting and distribution facility in Ponce that pursues revitalizing the sector and increasing manufacturing capacity to export the product.
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
